| Also known as |
Lumigan, Latisse when used for eyelash growth |
| Blood pressure |
No significant effect on systemic blood pressure |
| Chemical name |
(Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-5-N-ethylheptenamide |
| Dosage (medical) |
Typically 0.03% solution, one drop in the affected eye(s) once daily |
| Dosage (sports) |
Not applicable |
| Effects |
Reduces intraocular pressure, promotes eyelash growth |
| Formula |
C25H37NO4 |
| Half-life |
Approximately 45 minutes in human plasma |
| Hepatotoxicity |
No known hepatotoxic effects |
| Lab Test |
Not typically required for monitoring |
| Main action |
Lowers intraocular pressure |
| Side effects |
Eye irritation, dry eye, eye redness, growth of eyelashes, darkening of the iris |
| Storage conditions |
Store at 2В°C to 25В°C (36В°F to 77В°F) |
| Substance class |
Prostaglandin analog |
| Trade name |
Lumigan, Latisse |
| Use in sports |
None |
| Water Retention |
No significant effect |
| Manufacturer |
Pharmaceutical |
